Navigation Links
Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results
Date:11/6/2007

/p>

ASSETS

Cash and cash equivalents $51,285 $55,892

Marketable securities 52,519 71,251

Receivables from related party 7,758 12,035

Other current assets 7,527 8,427

Total current assets 119,089 147,605

Property and equipment, net 17,261 17,448

Marketable securities, non-current 32,678 59,208

Other assets 8,772 4,204

Total assets $177,800 $228,465

LIABILITIES AND STOCKHOLDERS' EQUITY

Accounts payable and accrued expenses $29,276 $23,429

Deferred revenue, related party 9,123 13,490

Other current liabilities 500 527

Total current liabilities 38,899 37,446

Long-term obligations 7,422 8,523

Deferred revenue, related party, net of

current position 43,335 40,471

Total liabilities 89,656 86,440

Stockholders' equity 88,144 142,025

Total liabilities and stockholders' equity $177,800 $228,465


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 2015 In 2014, the FDA approved ... tops the list scoring 4 drug approvals in the ... all FDA approved drug products, followed by oncology therapy ... anti-PCSK9, anti-PD1 and CDK inhibitors keep on attracting large-cap ... FDA to treat metastatic melanoma, and at present, they ...
(Date:3/5/2015)... 2015 AxoGen, Inc. (NASDAQ: AXGN) ... peripheral nerve repair market, reported record revenue of $4.79 ... compared to $2.98 million in the year-ago fourth quarter ... , “Our strong fourth quarter revenue growth reflects ... products which is driving increased surgeon adoption of our ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 ... this March with extra savings on their ... important of health and nutrition, HomeCEUConnection.com is ... using the promo code, NUTRITION2015 . ... Professionals , HomeCEUConnection.com provides high-quality continuing ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 TCS Healthcare ... solutions for the population health management arena, is pleased ... case management software, ACUITY Advanced Care™ (ACUITY) version 7.20. ... improved performance and the advantages of automation. , The ... ET, will be led by Jeff Frater, RN, BSN, ...
(Date:3/5/2015)... Ore. (PRWEB) March 05, 2015 ... sciences university founded in 1904, has launched a ... and positive lifestyle changes. The Northwest Center for ... health professionals, support community outreach, and conduct research ... functional medicine, diet and nutrition. The center will ...
Breaking Medicine News(10 mins):Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2
... assistant professor with the Virginia Tech College of Engineering ... mathematical framework that can track the spread of pandemics ... well as how a blackout occurring on one major ... networks to fail. Funded by the U.S. Department ...
... ... about snacking as football, where Americans munch156 billion extra calories in snacks. ... for people with diabetes, blood sugar problems and those trying to control ... and other medical conditions naturally is giving away free recipes for diabetes-friendly ...
... say , THURSDAY, Feb. 4 (HealthDay News) -- For many ... time, eventually leading to a diagnosis of major depression, according ... of 348 adults who had been diagnosed with mild depressive ... treatment for depression at the time of the visit and ...
... ... , ... 4, 2010 -- LimoRes.com, the leading global ground transportation provider, today announces a partnership ... SUV and van service with exclusive rates on www.LimoRes.com/RCCL . LimoRes.com will begin ...
... ... bone marrow drive at Borough of Manhattan Community College. , ... New York, NY (Vocus) February 4, 2010 -- Yesterday, Borough of Manhattan ... York Blood Center (NYBC) and The City University of New York (CUNY). , , , , ...
... , ... Bionorica, the world,s leading maker of clinically proven, plant-based natural ... two episodes of the series "Healing Quest," currently airing on select ... continue to be seen on PBS stations throughout 2010. A full ...
Cached Medicine News:Health News:Researcher to track spread of disease, malware and power outages 2Health News:New Website Giving Away Diabetes-Friendly Super Bowl Munchies Recipes to Tackle America's Toughest Health Problem 2Health News:New Website Giving Away Diabetes-Friendly Super Bowl Munchies Recipes to Tackle America's Toughest Health Problem 3Health News:New Website Giving Away Diabetes-Friendly Super Bowl Munchies Recipes to Tackle America's Toughest Health Problem 4Health News:Untreated, Mild May Become Major Depression 2Health News:Royal Caribbean International and LimoRes.com Announce Exclusive Partnership 2Health News:Saving Jennifer Jones Austin 2Health News:Saving Jennifer Jones Austin 3Health News:Saving Jennifer Jones Austin 4Health News:Bionorica's Natural Remedies Featured on PBS 'Healing Quest' Series 2Health News:Bionorica's Natural Remedies Featured on PBS 'Healing Quest' Series 3Health News:Bionorica's Natural Remedies Featured on PBS 'Healing Quest' Series 4
(Date:3/5/2015)... March 5, 2015 WuXi PharmaTech (Cayman) Inc. ... capability and technology platform company serving the pharmaceutical, biotechnology, ... the United States, today announced its financial results for ... Fourth-Quarter 2014 Highlights , Net Revenues Increased ... Laboratory Services Net Revenues Grew 17.7% Year Over Year ...
(Date:3/5/2015)... Germany , March 5, 2015 ... today announced that the foundation has made a ... CureVac, a leading clinical-stage biopharmaceutical company specializing in ... the foundation will also provide separate funding for ... CureVac,s proprietary messenger RNA (mRNA) platform. In addition, ...
(Date:3/5/2015)... , March 5, 2015 CANTEL MEDICAL CORP. ... its second quarter ended January 31, 2015 on Thursday, March ... to discuss the results at 11:00 AM ET. ... approximately 5 to 10 minutes before the beginning of the ... of the call will be available from Thursday, March 12, ...
Breaking Medicine Technology:WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 2WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 3WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 4WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 5WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 6WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 7WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 8WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 9WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 10WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 11WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 12WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 13WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 14WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 15WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 16WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 17WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 18WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 19WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 20WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 21WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 22The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 2The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 3The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 4Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2015 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: